Want to see CGTX full AI Analyst Report?
Cognition Therapeutics (CGTX) Income Statement
Cognition Therapeutics Income Statement
Last quarter (Q2 2026), Cognition Therapeutics's total revenue was $0.00. In Q2, Cognition Therapeutics's net income was $-3.93M. See Cognition Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ 0.00 | $ 0.00 | $ -235.00K | $ 0.00 | |
| $ 47.80M | $ 53.97M | $ 50.72M | $ 43.32M | $ 28.60M | |
| Depreciation and Amortization | $ 228.00K | $ 266.00K | $ 252.00K | $ 235.00K | $ 93.00K |
| $ -23.25M | $ -33.68M | $ -25.51M | $ -21.13M | $ -10.73M | |
| $ -47.80M | $ -53.97M | $ -50.72M | $ -43.55M | $ -28.60M | |
| $ 24.31M | $ 20.00M | $ 24.94M | $ 22.15M | $ 16.88M | |
| $ -23.49M | $ -33.97M | $ -25.79M | $ -21.40M | $ -11.72M | |
| $ -23.49M | $ -33.97M | $ -25.79M | $ 757.00K | $ -11.72M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.32 | $ -0.85 | $ -0.86 | $ -0.74 | $ -0.73 |
| Diluted EPS | $ -0.32 | $ -0.85 | $ -0.86 | $ -0.74 | $ -0.73 |
| Weighted Average Shares Outstanding | 72.77M | 39.73M | 29.99M | 28.99M | 22.23M |
| Weighted Average Shares Outstanding (Diluted) | 72.77M | 39.73M | 30.03M | 28.99M | 22.23M |
Currency in USD